Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Roche pays $2.4 billion for rest of cancer expert Foundation Medicine

Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising the Swiss drugmaker’s bet on the U.S. genomic profiling group’s ability to personalize cancer care.

Read More »

Kentucky sues Walgreens Boots Alliance

Kentucky’s attorney general sued Walgreens Boots Alliance Inc., accusing the company of playing a role in propagating an opioid epidemic in the state.

Read More »

J&J accepts $2.1 billion offer for LifeScan unit

Johnson & Johnson has accepted private equity firm Platinum Equity’s $2.1 billion buyout offer for the company’s LifeScan unit.

Read More »

Novartis Pays Regenxbio $100 Million for Gene Therapy Technology Under AveXis License Agreement

Rockville, Md.-based REGENXBIO snagged $100 million from Novartis under its license agreement with gene-therapy company AveXis, which the Swiss company acquired for $8.7 billion earlier in 2018.

Read More »

Melinta Therapeutics: $123 Million in Public Offering

New Haven, Conn.-based Melinta Therapeutics snagged $123 million in a public offering of 22,000,000 shares of its common stock.

Read More »

Translate Bio and Sanofi Ink Potential $850 Million mRNA Vaccine Development Deal

Translate Bio, headquartered in Lexington, Massachusetts, and Paris-based Sanofi are teaming up to develop five vaccines.

Read More »

Biotech’s Soon-Shiong hiring bankers for Nant cancer drug IPO

Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public during 2018 and has begun hiring bankers, the biotechnology entrepreneur told Reuters.

Read More »

French Company Ipsen to Move U.S. Headquarters to Boston

Ipsen plans to relocate the French company’s U.S. operations from New Jersey to Kendall Square in Cambridge, Mass.

Read More »

Bill and Melinda Gates Foundation Spins Out a Nonprofit Biotech Company

The Bill & Melinda Gates Foundation spun off a biotech company called The Bill & Melinda Gates Medical Research Institute (MRI) located in Boston.

Read More »

Biogen Options Stroke Drug from TMS

Biogen, headquartered in Cambridge, Massachusetts, signed an exclusive option deal with Tokyo-based TMS for TMS-007 and backup compounds.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom